Daster K, Hench J, Diepenbruck M, Volkmann K, et al. BRCA promoter methylation in triple-negative breast cancer is preserved in xenograft models and represents a potential therapeutic marker for PARP inhibitors. Breast Cancer Res Treat 2024 Oct 11. doi: 10.1007/s10549-024-07502.
PMID: 39392573